by Sue Robbins | Aug 25, 2019 | Migraine
Migraine and insomnia are both common disorders, with prevalence estimates of 12% and 10% in the United States, respectively.1,2 A substantial body of research shows that the 2 conditions are linked in numerous ways and suggests a bidirectional relationship. Read more...
by Sue Robbins | Aug 22, 2019 | Migraine
It’s bad enough to have an aching head, but about one in 10 people who suffer from headaches also experience facial pain, researchers have found. Read more here.
by Sue Robbins | Aug 20, 2019 | Migraine
Ubrogepant has demonstrated efficacy in treating acute migraine among individuals for whom triptan has not been effective. Read more here.
by Sue Robbins | Aug 18, 2019 | Migraine
Through the Global Burden of Diseases, Injuries, and Risk Factors (GBD) studies, headache has emerged as a major global public health concern. We aimed to use data from the GBD 2016 study to provide new estimates for prevalence and years of life lived with disability...
by Sue Robbins | Aug 18, 2019 | Migraine
Pfizer Inc. issued a voluntary nationwide recall Wednesday for two lots of Relpax (eletriptan hydrobromide) 40-milligram tablets due to the potential contamination. The lots are AR5407 and CD4565. Read more here.
by Sue Robbins | Aug 15, 2019 | Migraine
Migraine is underdiagnosed and undertreated, said Dawn C. Buse, PhD, clinical professor of neurology at Albert Einstein College of Medicine, New York, and colleagues. Read more here.
